canqert.blogg.se - Xact analysis

Xact analysis manual#

Previously placed stent in target artery.Low to moderate risk for adverse events from carotid endarterectomy.The safety and effectiveness of the Xact Carotid Stent System has NOT yet been established in patients with the characteristics noted below. When multiple stents are required, stent materials should be of similar composition. Special consideration should be given to those patients with recently active gastritis or peptic ulcer disease. The appropriate antiplatelet and anticoagulation therapy should be administered pre- and post-procedure as suggested in these instructions. In patients requiring the use of antacids and / or H2-antagonists before or immediately after stent placement, oral absorption of antiplatelet agents (e.g.

Stenting across a major bifurcation may hinder or prevent future diagnostic or therapeutic procedures. The long-term performance (> 1 year) of the Xact Carotid Stent System has not been established.Īs with any type of vascular implant, infection secondary to contamination of the stent may lead to thrombosis, pseudoaneurysm, or rupture. The safety and efficacy of the Xact Carotid Stent System has not been demonstrated with embolic protection systems other than the Emboshield Embolic Protection System. Refer to instructions supplied with all interventional devices to be used with the Xact Carotid Stent System for their intended uses, contraindications, and potential complications. Only physicians who have received appropriate training and are familiar with the principles, clinical applications, complications, side effects and hazards commonly associated with carotid interventional procedures should use this device.

Lesions in the ostium of the common carotid artery.

Patients with uncorrected bleeding disorders.

Patients with a known hypersensitivity to nickel-titanium.

Patients with severe vascular tortuosity or anatomy that would preclude the safe introduction of the Guiding Catheter / Introducer Sheath, BareWire guide wire, Emboshield Delivery Catheter, Filtration Element, and / or Retrieval Catheter.

Patients in whom anticoagulant and / or antiplatelet therapy is contraindicated.

Patients must have a reference vessel diameter ranging between 4.8 mm and 9.1 mm at the target lesion.Ĭontraindications associated with angioplasty must be considered when using the Xact Carotid Stent System. Patients with carotid artery stenosis (≥ 50% for symptomatic patients by ultrasound or angiography or ≥ 80% for asymptomatic patients by ultrasound or angiography), located between the origin of the common carotid artery and the intra-cranial segment of the internal carotid artery AND We are excited to see the fruits of the integration take hold and know we’ll always seek to find better ways to benefit both our insurance company clients and our independent adjustment firm.The Xact Carotid Stent System (Xact), used in conjunction with the Emboshield Embolic Protection System is indicated for the improvement of the lumen diameter of carotid arteries in patients considered at high risk for adverse events from carotid endarterectomy who require percutaneous carotid angioplasty and stenting for occlusive artery disease and meet the criteria outlined below: On the back-end, when the adjustment is completed, settlement draft amounts will automatically be generated by Guidewire from XactAnalysis saving input time on the company end. The benefits of integration go beyond those front-end improvements. Prior to this integration, manually pulling this information from the carrier systems (either by the insurer or adjustment firm) created opportunities for errors and delays. XactAnalysis (via Guidewire) also provides the necessary claim details and documents (declaration page and First Notice of Loss) to the adjuster accurately and immediately.

Xact analysis manual#

This new flow reduces the need for manual set-up in Xactimate by sending the assignment with all details to the adjustment firm via XactAnalysis. On the front-end of the new claim workflow, the insurer can make assignments directly from Guidewire. The client wished to continue using the Guidewire environment which manages both their underwriting and claims processes while adding benefits only available by incorporating their current workflow with XactAnalysis. I recently had the pleasure of assisting an insurance company client of ours in integrating their claims processing with XactAnalysis. The benefits are substantial in time saved and increased consistency. System integration with independent adjusters can pair greater accuracy and speed with transactional ease. Insurance carriers are continually seeking to remove friction points in their claims processes.